Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07TQN
|
||||
Former ID |
DCL000704
|
||||
Drug Name |
Asimadoline
|
||||
Synonyms |
Asimadoline [INN]; EMD 61753; N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diarrhea-predominant IBS [ICD9: 564.1; ICD10:K58.0] | Phase 3 | [536224] | ||
Company |
Merck
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H30N2O2
|
||||
Canonical SMILES |
CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=C<br />C=C4
|
||||
InChI |
1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1
|
||||
InChIKey |
JHLHNYVMZCADTC-LOSJGSFVSA-N
|
||||
CAS Number |
CAS 153205-46-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
R05DA11
|
||||
SuperDrug CAS ID |
cas=036309010
|
||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Agonist | [536224] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.